Liquid Biopsy Market: By Product Type By Application Type By Sample Type By End User and Region Forecast 2019 - 2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Liquid Biopsy Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Consumables, Instruments) By Application Type (Blood, Urine Others) By Sample Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer Others) By End User (Hospitals, Diagnostic Laboratories, Academic and Research Centers Others) and Region Forecast 2019 - 2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Liquid Biopsy Market size was valued at US$ 899.0 million in 2023 and is expected to reach US$ 2989.9 million by 2030, at a CAGR of 22.2% from 2024-2030. The market is gaining traction in recent times owing to its accurate, effective results in comparison with traditional cancer screening methods, which are achieved through minimal invasiveness and expenses. Challenges associated with traditional biopsies such as invasiveness, ill-informed results, post-sampling medical challenges, and costs are prompting healthcare professionals to adopt less invasive liquid biopsy tests for cancer screening and management, which is projected to create significant market demand for liquid biopsy products and services over the forecast period.

Moreover, several clinical research activities related to biomarkers are in the late stage and it is expected that upon successful launch and commercialization of these tests over the forecast period will result in significant market growth. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, This report includes new product introductions; regulatory scenarios, and competition analyses with a vividly illustrated competition dashboard to assess the market competition.  

summary download arrow Download Free Sample

Liquid Biopsy Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

22.2%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Liquid Biopsy Market Dynamics

Players in the global liquid biopsy market increasingly attracting the investments in recent times for development and commercialization of late-stage products through IPOs. For instance, RainDance Technologies and Biocept filled IPOs in 2015 and 2014 respectively to develop advanced liquid biopsy technologies to aid physicians to devise suitable treatment strategies. Moreover, growing awareness among key stakeholders regarding liquid biopsy assays expected to drive market demand for these tests over the forecast period across the globe.

Liquid Biopsy Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 899.0 million

Market Size in 2030

US$ 2989.9 million

Market CAGR

22.2%

By Product Type

  • Instruments
  • Reagents
  • Services and Software

By Sample

  • Blood Samples
  • Urine Samples
  • Other Biofluid Samples

By Application

  • Breast Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Leukemia
  • Lung Cancer
  • Prostate Cancer
  • Other Cancers

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes

By Region

  • North America (USA, Canada)
  • Europe (Germany, UK, France, Spain, Italy , Rest of Europe)
  • The Asia Pacific (China, India, Japan, Australia, South Korea, Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • MEA (Saudi Arabia, UAE, South Africa, Rest of MEA)

Key Features of the Report

  • The liquid biopsy market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global liquid biopsy market size was valued at US$ 899.0 million in 2023 and is projected to grow at a CAGR of 22.2% from 2024 to 2030.

The market's key players are: Catabasis Pharmaceuticals Inc. NS Pharma, Inc Marathon Pharmaceuticals, LLC ITALFARMACO S.p.A. FibroGen, Inc. Summit Therapeutics plc PTC Therapeutics Santhera Pharmaceuticals Sarepta Therapeutics, Inc.

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive summary
2. Global Liquid Biopsy Market Introduction
2.1. Global Liquid Biopsy Market – Taxonomy
2.2. Global Liquid Biopsy Market –Definitions
2.2.1. By Product Type
2.2.2. By Application Type
2.2.3. By Sample Type
2.2.4. By End User
3. Global Liquid Biopsy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Liquid Biopsy Market Dynamics – Factors Impact Analysis
3.6. Global Liquid Biopsy Market – Regulations
3.6.1. The U.S.
3.6.2. Europe
3.7. Federal Grants for Liquid Biopsy Startups
3.8. Venture Capital Investments in Liquid Biopsy Companies
3.9. Product Innovations
3.10. Startups working in the Liquid Biopsy
3.11. Novel Applications of Liquid Biopsy
4. Global Liquid Biopsy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Liquid Biopsy Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2030
5.1. Consumables
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Liquid Biopsy Market, By Sample Type, 2019 - 2023 and Forecast, 2024 - 2030
6.1. Blood
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Urine
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3. Others
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7. Global Liquid Biopsy Market Forecast, By Application Type, 2019 - 2023 and Forecast, 2024 - 2030
7.1.  Lung Cancer
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Breast Cancer
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Colorectal Cancer
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Prostate Cancer
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Liver Cancer
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Liquid Biopsy Market Forecast, By End User Type, 2019 - 2023 and Forecast, 2024 - 2030
8.1.  Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Diagnostic Laboratories
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic and Research Centers
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Liquid Biopsy Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Liquid Biopsy Market - Opportunity Analysis Index, By Product Type, By Application Type, Sample Type, End User, and Region, 2024 - 2030
10. North America Liquid Biopsy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
10.1. By Product Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables
10.1.2. Instruments
10.2. By Sample Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Blood
10.2.2. Urine
10.2.3. Others
10.3. Application Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Lung Cancer
10.3.2. Breast Cancer
10.3.3. Colorectal Cancer
10.3.4. Prostate Cancer
10.3.5. Liver Cancer
10.3.6. Others
10.4. End User Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Academic and Research Centers
10.4.4. Others
10.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Liquid Biopsy Market - Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2024 - 2030
10.7. North America Liquid Biopsy Market Dynamics – Trends
11. Europe Liquid Biopsy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
11.1. By Product Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables
11.1.2. Instruments
11.2. By Sample Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Blood
11.2.2. Urine
11.2.3. Others
11.3. Application Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Lung Cancer
11.3.2. Breast Cancer
11.3.3. Colorectal Cancer
11.3.4. Prostate Cancer
11.3.5. Liver Cancer
11.3.6. Others
11.4. End User Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Academic and Research Centers
11.4.4. Others
11.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Holland
11.5.9. Rest of Europe
11.6. Europe Liquid Biopsy Market - Opportunity Analysis Index, Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2024 - 2030
11.7. Europe Liquid Biopsy Market Dynamics – Trends
12. Asia-Pacific Liquid Biopsy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
12.1. By Product Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables
12.1.2. Instruments
12.2. By Sample Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Blood
12.2.2. Urine
12.2.3. Others
12.3. Application Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Lung Cancer
12.3.2. Breast Cancer
12.3.3. Colorectal Cancer
12.3.4. Prostate Cancer
12.3.5. Liver Cancer
12.3.6. Others
12.4. End User Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Academic and Research Centers
12.4.4. Others
12.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Liquid Biopsy Market - Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2024 - 2030
12.7. Asia-Pacific Liquid Biopsy Market Dynamics – Trends
13. Latin America Liquid Biopsy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
13.1. By Product Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Consumables
13.1.2. Instruments
13.2. By Sample Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Blood
13.2.2. Urine
13.2.3. Others
13.3. Application Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Lung Cancer
13.3.2. Breast Cancer
13.3.3. Colorectal Cancer
13.3.4. Prostate Cancer
13.3.5. Liver Cancer
13.3.6. Others
13.4. End User Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Academic and Research Centers
13.4.4. Others
13.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Liquid Biopsy Market - Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2024 - 2030
13.7. Latin America Liquid Biopsy Market Dynamics – Trends
14. Middle East and Africa Liquid Biopsy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
14.1. By Product Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Consumables
14.1.2. Instruments
14.2. By Sample Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Blood
14.2.2. Urine
14.2.3. Others
14.3. Application Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Lung Cancer
14.3.2. Breast Cancer
14.3.3. Colorectal Cancer
14.3.4. Prostate Cancer
14.3.5. Liver Cancer
14.3.6. Others
14.4. End User Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Academic and Research Centers
14.4.4. Others
14.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Liquid Biopsy Market - Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2024 - 2030
14.7. MEA Liquid Biopsy Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Catabasis Pharmaceuticals Inc.
15.2.2. NS Pharma, Inc
15.2.3. Marathon Pharmaceuticals, LLC
15.2.4. ITALFARMACO S.p.A.
15.2.5. FibroGen, Inc.
15.2.6. Summit Therapeutics plc
15.2.7. PTC Therapeutics
15.2.8. Santhera Pharmaceuticals
15.2.9. Sarepta Therapeutics, Inc.
16. Research Methodology
17. Key Assumptions and Acronyms

Key Market Players

  • Catabasis Pharmaceuticals Inc.
  • NS Pharma, Inc
  • Marathon Pharmaceuticals, LLC
  • ITALFARMACO S.p.A.
  • FibroGen, Inc.
  • Summit Therapeutics plc
  • PTC Therapeutics
  • Santhera Pharmaceuticals
  • Sarepta Therapeutics, Inc.

Related Industry Reports

Breast Cancer Screening Market

Global Blood Glucose Measurement Market

Global Blood Grouping Reagents Market

Global Breast Cancer Treatment Market